Synergistic effects of Y2 and Y4 receptors on adiposity and bone mass revealed in double knockout mice
- PMID: 12861009
- PMCID: PMC165708
- DOI: 10.1128/MCB.23.15.5225-5233.2003
Synergistic effects of Y2 and Y4 receptors on adiposity and bone mass revealed in double knockout mice
Abstract
Neuropeptide Y regulates numerous physiological processes via at least five different Y receptors, but the specific roles of each receptor are still unclear. We previously demonstrated that Y2 receptor knockout results in a lean phenotype, increased cancellous bone volume, and an increase in plasma pancreatic polypeptide (PP), a ligand for Y4 receptors. PP-overexpressing mice are also known to have a lean phenotype. Deletion of the Y4 receptor also produced a lean phenotype and increased plasma PP levels. We therefore hypothesized that part of the Y2 phenotype results from increased PP action on Y4 receptors and tested this in PP transgenic Y4(-/-) and Y2(-/-) Y4(-/-) double knockout mice. Bone mass was not altered in Y4 knockout mice. Surprisingly, despite significant hyperphagia, Y2(-/-) Y4(-/-) mice retained a markedly lean phenotype, with reduced body weight, white adipose tissue mass, leptinemia, and insulinemia. Furthermore, bone volume was also increased threefold in Y2(-/-) Y4(-/-) mice, and this was associated with enhanced osteoblastic activity. These changes were more pronounced than those observed in Y2(-/-) mice, suggesting synergy between Y2 and Y4 receptor pathways. The lack of bone changes in PP transgenic mice suggests that PP alone is not responsible for the bone mass increases but might play a major role in the lean phenotype. However, a synergistic interaction between Y2 and Y4 pathways seems to regulate bone volume and adiposity and could have important implications for possible interventions in obesity and for anabolic treatment of osteoporotic bone loss.
Figures







Similar articles
-
Synergistic attenuation of obesity by Y2- and Y4-receptor double knockout in ob/ob mice.Nutrition. 2008 Sep;24(9):892-9. doi: 10.1016/j.nut.2008.06.019. Epub 2008 Jul 26. Nutrition. 2008. PMID: 18662863
-
Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice.Neuroscience. 2009 Feb 18;158(4):1717-30. doi: 10.1016/j.neuroscience.2008.11.048. Epub 2008 Dec 9. Neuroscience. 2009. PMID: 19121371 Free PMC article.
-
Y2 and Y4 receptor signaling synergistically act on energy expenditure and physical activity.Am J Physiol Regul Integr Comp Physiol. 2010 Dec;299(6):R1618-28. doi: 10.1152/ajpregu.00345.2010. Epub 2010 Sep 29. Am J Physiol Regul Integr Comp Physiol. 2010. PMID: 20881101
-
NPY and Y receptors: lessons from transgenic and knockout models.Neuropeptides. 2004 Aug;38(4):189-200. doi: 10.1016/j.npep.2004.05.005. Neuropeptides. 2004. PMID: 15337371 Review.
-
A role for pancreatic polypeptide in feeding and body weight regulation.Peptides. 2007 Feb;28(2):459-63. doi: 10.1016/j.peptides.2006.09.024. Epub 2007 Jan 4. Peptides. 2007. PMID: 17207558 Review.
Cited by
-
Targeting the central and peripheral nervous system to regulate bone homeostasis: mechanisms and potential therapies.Mil Med Res. 2025 Mar 20;12(1):13. doi: 10.1186/s40779-025-00600-8. Mil Med Res. 2025. PMID: 40108680 Free PMC article. Review.
-
Evidence from knockout mice for distinct implications of neuropeptide-Y Y2 and Y4 receptors in the circadian control of locomotion, exploration, water and food intake.Neuropeptides. 2009 Dec;43(6):491-7. doi: 10.1016/j.npep.2009.08.007. Epub 2009 Sep 24. Neuropeptides. 2009. PMID: 19781771 Free PMC article.
-
The NPY system and its neural and neuroendocrine regulation of bone.Curr Osteoporos Rep. 2012 Jun;10(2):160-8. doi: 10.1007/s11914-012-0102-7. Curr Osteoporos Rep. 2012. PMID: 22477260 Review.
-
Long-acting PYY3 -36 analogue with semaglutide for obesity: from preclinical assessment through randomized clinical studies.Obesity (Silver Spring). 2025 Aug;33(8):1457-1474. doi: 10.1002/oby.24329. Epub 2025 Jul 8. Obesity (Silver Spring). 2025. PMID: 40629530 Free PMC article. Clinical Trial.
-
NPY neuron-specific Y2 receptors regulate adipose tissue and trabecular bone but not cortical bone homeostasis in mice.PLoS One. 2010 Jun 29;5(6):e11361. doi: 10.1371/journal.pone.0011361. PLoS One. 2010. PMID: 20613867 Free PMC article.
References
-
- Abe, M., M. Saito, and T. Shimazu. 1989. Neuropeptide Y and norepinephrine injected into the paraventricular nucleus of the hypothalamus activate endocrine pancreas. Biomed. Res. 10:431-436.
-
- Aubert, M. L., D. D. Pierroz, N. M. Gruaz, V. d'Alleves, B. A. Vuagnat, F. P. Pralong, W. F. Blum, and P. C. Sizonenko. 1998. Metabolic control of sexual function and growth: role of neuropeptide Y and leptin. Mol. Cell. Endocrinol. 140:107-113. - PubMed
-
- Baran, K., E. Preston, D. Wilks, G. J. Cooney, E. W. Kraegen, and A. Sainsbury. 2002. Chronic central melanocortin-4 receptor antagonism and central neuropeptide-Y infusion in rats produce increased adiposity by divergent pathways. Diabetes 51:152-158. - PubMed
-
- Bard, J. A., M. W. Walker, T. A. Branchek, and R. L. Weinshank. 1995. Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY. J. Biol. Chem. 270:26762-26765. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous